Wedmont Private Capital’s Moderna MRNA Stock Holding History

Wedmont Private Capital’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$261K	Sell	3,822 -727	-16%	-$37.6K	0.01%	801
2026 Q1	$237K	Buy	+4,549	New	+$212K	0.01%	748
2024 Q3	–	Sell	-3,075	Closed	-$373K	–	685
2024 Q2	$373K	Buy	3,075 +1,003	+48%	+$127K	0.02%	422
2024 Q1	$231K	Buy	+2,072	New	+$209K	0.02%	524
2023 Q2	–	Sell	-2,087	Closed	-$334K	–	513
2023 Q1	$334K	Sell	2,087 -1,428	-41%	-$236K	0.04%	309
2022 Q4	$634K	Buy	+3,515	New	+$575K	0.09%	162
2022 Q3	–	Sell	-2,110	Closed	-$301K	–	394
2022 Q2	$301K	Sell	2,110 -1,237	-37%	-$177K	0.06%	234
2022 Q1	$577K	Buy	3,347 +1,276	+62%	+$215K	0.13%	126
2021 Q4	$435K	Buy	+2,071	New	+$606K	0.13%	123

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Wedmont Private Capital's MRNA Position: Q2 2026 in Review

Wedmont Private Capital reduced its Moderna (MRNA) stake by 16% in Q2 2026, selling an estimated $37.6K and leaving 3,822 shares worth $261K. The position accounts for 0.01% of the portfolio, ranked #801.

Wedmont Private Capital first reported a position in MRNA in Q4 2021 and has held it in 9 quarters since. The position peaked at $634K in Q4 2022. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Wedmont Private Capital held 3,822 shares of Moderna worth $261K as of Q2 2026.
Wedmont Private Capital sold 727 Moderna shares in Q2 2026, an estimated $37.6K.
Moderna made up 0.01% of Wedmont Private Capital's portfolio in Q2 2026, its #801 holding.
Wedmont Private Capital first reported a position in Moderna in Q4 2021 and has held it in 9 quarters since.
Wedmont Private Capital's Moderna position peaked at $634K in Q4 2022.
777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Wedmont Private Capital's 13F filing for Q2 2026, filed 13 Jul 2026.